| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.002 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0049 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |